Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Oral Leuprolide vs IM Leuprolide in Healthy Women
NCT02807363Phase 2Completed
- Sponsor
- Enteris BioPharma
- Start
- Aug 2017
- Primary completion
- Jun 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in endometriosis, sponsored by Enteris BioPharma. Started Aug 2017; status: completed.
02
Drugs
leuprolide
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02807363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807363.